TNGX earnings: a negative outcome, -7.1%

On March 18, 2024, Tango Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.1% in the window around the event. It had already run -24.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.